Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors. (APNEE REA)

October 10, 2016 updated by: Poitiers University Hospital
Clinical diagnostic of brain death requires a non-reactive coma, absence of brain stem reflex, and absence of spontaneous breathing. The confirmation of absence of spontaneous breathing is established the apnea test (according to the American Academy of Neurology's Guidelines). However this test may lead to complications (acute hypoxemia, ventilatory and cardiocirculatory disorders) and reduces significantly the number of lung transplants. Some data suggest modifying the apnea test : replace the ventilator switching off with continuous positive airway pressure (CPAP) use. These studies showed that this alternative method (CPAP) increased the level of lung harvest but they were not sufficient because these studies were monocentric with little patients,. That why the aim of the present study is to compare the standard strategy and CPAP strategy with a prospective, multicenter,cluster trial; each center will use the method of apnea test which it uses usually.

Study Overview

Study Type

Observational

Enrollment (Actual)

208

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • Angers University Hospital
      • Angoulême, France, 16959
        • Angouleme Hospital
      • Bordeaux, France, 33076
        • Bordeaux University Hospital
      • Brest, France, 29200
        • Brest University Hospital
      • Chambray-lès-Tours, France, 37170
        • Tours University Hospital
      • Corbeil-Essonnes, France, 91106
        • Sud Francilien Hospital
      • La Roche sur Yon, France, 85925
        • La Roche Sur Yon Hospital
      • La Rochelle, France, 17019
        • La Rochelle Hospital
      • Limoges, France, 87042
        • Limoges university hospital
      • Nantes, France, 44093
        • Nantes University Hospital
      • Nice, France, 06006
        • Nice University Hospital
      • Orléans, France, 45067
        • Orléans Hospital
      • Paris, France, 75679
        • Cochin University Hospital
      • Poitiers, France, 86000
        • Poitiers university hospital
      • Rennes, France, 35033
        • Rennes University Hospital
      • Saintes, France, 17108
        • Saintes Hospital
      • Toulon, France, 83056
        • Toulon University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Potentiel organs donors in brain death.

Description

Inclusion Criteria:

  • Age : from 18 to 75 years
  • Neurological signs evoking cerebral ischemia

Exclusion Criteria:

  • Severe hypoxemia (PaO2/FiO2 < 200) with controlled ventilation (FiO2: 100%)
  • Hypothermia < 36°C
  • Obesity (BMI ≥ 40) with documented hypopnoea
  • Intractable hypotension despite optimal filling and catecholamine doses > 1µg.Kg.min
  • Patients with contraindication for organs harvesting.
  • Documented chronic respiratory failure
  • Progressive infectious acute respiratory disease
  • Family opposition to subject's participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Standard group
Apnea test according to the recommendation
CPAP group
Apnea test with CPAP connection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Eligibility to lung harvest
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Levels of hypoxemia
Time Frame: 2 years
2 years
Arterial blood gas after apnea test
Time Frame: 2 years
2 years
Rate of ventilatory impairment
Time Frame: 2 years
2 years
Rate of cardiocirculatory impairment
Time Frame: 2 years
2 years
Rate of apnea test interruption
Time Frame: 2 years
2 years
Number of lung transplantation realization
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michel PINSARD, Hospital Practitioner, Poitiers university hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

July 26, 2013

First Submitted That Met QC Criteria

July 26, 2013

First Posted (Estimate)

July 30, 2013

Study Record Updates

Last Update Posted (Estimate)

October 11, 2016

Last Update Submitted That Met QC Criteria

October 10, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • APNEE REA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alternative Method of Apnea Test

Clinical Trials on Apnea test - CPAP

3
Subscribe